Omega Therapeutics (OMGA)
(Delayed Data from NSDQ)
$1.55 USD
+0.03 (1.97%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.56 +0.01 (0.65%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.31 |
EPS Last Quarter | -0.30 |
Last EPS Surprise | 16.67% |
ABR | 1.17 |
Earnings ESP
|
1.27% |
---|---|
Current Year | -1.23 |
Next Year | -1.06 |
EPS (TTM) | -1.43 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.25M | 1.25M | 5.10M | 3.92M |
# of Estimates | 3 | 3 | 5 | 4 |
High Estimate | 2.39M | 2.39M | 6.80M | 6.77M |
Low Estimate | 0.50M | 0.50M | 2.54M | 1.50M |
Year ago Sales | 0.83M | 0.99M | 3.10M | 5.10M |
Year over Year Growth Est. | 50.12% | 25.86% | 64.85% | -23.23% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.31 | -0.25 | -1.23 | -1.06 |
# of Estimates | 5 | 5 | 6 | 6 |
Most Recent Consensus | -0.29 | -0.28 | -1.23 | -1.11 |
High Estimate | -0.24 | -0.18 | -1.10 | -0.60 |
Low Estimate | -0.40 | -0.33 | -1.51 | -1.79 |
Year ago EPS | -0.40 | -0.37 | -1.80 | -1.23 |
Year over Year Growth Est. | 22.50% | 32.43% | 31.67% | 13.95% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 3 | 4 | 4 |
Up Last 60 Days | 2 | 3 | 4 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.31 | -0.25 | -1.23 | -1.06 |
7 Days Ago | -0.31 | -0.25 | -1.23 | -1.06 |
30 Days Ago | -0.32 | -0.28 | -1.31 | -1.19 |
60 Days Ago | -0.32 | -0.28 | -1.31 | -1.19 |
90 Days Ago | -0.31 | -0.28 | -1.30 | -1.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.31 | -0.23 | -1.19 | -0.92 |
Zacks Consensus Estimate | -0.31 | -0.25 | -1.23 | -1.06 |
Earnings ESP | 1.27% | 9.33% | 3.71% | 13.72% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.30 | -0.36 | -0.37 | -0.40 | NA |
Estimate | -0.36 | -0.38 | -0.46 | -0.56 | NA |
Difference | 0.06 | 0.02 | 0.09 | 0.16 | 0.08 |
Surprise | 16.67% | 5.26% | 19.57% | 28.57% | 17.52% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more